Br J Ophthalmol: Most-Read Full-Text Articles
http://bjo.bmj.com/
Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.2013-05-03<![CDATA[The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss]]>
http://bjo.bmj.com/cgi/content/short/97/5/632?rss=1&ssource=mfr
May 1, 2013; 97:632-636 Original articles - Clinical science]]>Lyndon da Cruz, Brian F Coley, Jessy Dorn, Francesco Merlini, Eugene Filley, Punita Christopher, Fred K Chen, Varalakshmi Wuyyuru, Jose Sahel, Paulo Stanga, Mark Humayun, Robert J Greenberg, Gislin Dagnelie, for the Argus II Study Group2013-05-01BMJ Publishing Group Ltd5976362013-05-01Original articles - Clinical science632<![CDATA[A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients]]>
http://bjo.bmj.com/cgi/content/short/96/10/1310?rss=1&ssource=mfr
Oct 1, 2012; 96:1310-1315 Original articles - Clinical science]]>Etsuko Takamura, Kazuo Tsubota, Hitoshi Watanabe, Yuichi Ohashi, for The Diquafosol Ophthalmic Solution Phase 3 Study Group2012-10-01BMJ Publishing Group Ltd109613152012-10-01Original articles - Clinical science1310<![CDATA[Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus]]>
http://bjo.bmj.com/cgi/content/short/97/4/433?rss=1&ssource=mfr
Apr 1, 2013; 97:433-437 Original articles - Clinical science]]>David P S O''Brart, Tsong Q Kwong, Parul Patel, Robert J McDonald, Naomi A O''Brart2013-04-01BMJ Publishing Group Ltd4974372013-04-01Original articles - Clinical science433<![CDATA[Findings of perinatal ocular examination performed on 3573, healthy full-term newborns]]>
http://bjo.bmj.com/cgi/content/short/97/5/588?rss=1&ssource=mfr
May 1, 2013; 97:588-591 Original articles - Clinical science]]>Li-Hong Li, Na Li, Jun-Yang Zhao, Ping Fei, Guo-ming Zhang, Jian-bo Mao, Paul J Rychwalski2013-05-01BMJ Publishing Group Ltd5975912013-05-01Original articles - Clinical science588<![CDATA[Emerging concepts in the management of acute retinal necrosis]]>
http://bjo.bmj.com/cgi/content/short/97/5/545?rss=1&ssource=mfr
May 1, 2013; 97:545-552 ]]>Robert William Wong, J Michael Jumper, H Richard McDonald, Robert N Johnson, Arthur Fu, Brandon J Lujan, Emmett T Cunningham Jr2013-05-01BMJ Publishing Group Ltd5975522013-05-01545<![CDATA[Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy]]>
http://bjo.bmj.com/cgi/content/short/97/5/617?rss=1&ssource=mfr
May 1, 2013; 97:617-621 Original articles - Clinical science]]>Taiichi Hikichi, Makoto Higuchi, Takuro Matsushita, Shoko Kosaka, Reiko Matsushita, Kimitaka Takami, Hideo Ohtsuka, Hirokuni Kitamei, Shoko Shioya2013-05-01BMJ Publishing Group Ltd5976212013-05-01Original articles - Clinical science617<![CDATA[VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study]]>
http://bjo.bmj.com/cgi/content/short/97/3/278?rss=1&ssource=mfr
Mar 1, 2013; 97:278-284 Original articles - Clinical science]]>Frank G Holz, Johann Roider, Yuichiro Ogura, Jean-Francois Korobelnik, Christian Simader, Georg Groetzbach, Robert Vitti, Alyson J Berliner, Florian Hiemeyer, Karola Beckmann, Oliver Zeitz, Rupert Sandbrink2013-03-01BMJ Publishing Group Ltd3972842013-03-01Original articles - Clinical science278<![CDATA[Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema]]>
http://bjo.bmj.com/cgi/content/short/97/4/454?rss=1&ssource=mfr
Apr 1, 2013; 97:454-459 Original articles - Clinical science]]>Claus Zehetner, Rudolf Kirchmair, Stefan Huber, Martina T Kralinger, Gerhard F Kieselbach2013-04-01BMJ Publishing Group Ltd4974592013-04-01Original articles - Clinical science454<![CDATA[Generic medications in ophthalmology]]>
http://bjo.bmj.com/cgi/content/short/97/3/253?rss=1&ssource=mfr
Mar 1, 2013; 97:253-257 ]]>Matt Zore, Alon Harris, Leslie Abrams Tobe, Brent Siesky, Ingrida Januleviciene, Jennifer Behzadi, Annahita Amireskandari, Patrick Egan, Kevin Garff, Barbara Wirostko2013-03-01BMJ Publishing Group Ltd3972572013-03-01253<![CDATA[A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration]]>
http://bjo.bmj.com/cgi/content/short/97/3/266?rss=1&ssource=mfr
Mar 1, 2013; 97:266-271 Original articles - Clinical science]]>Ilse Krebs, Leopold Schmetterer, Agnes Boltz, Reinhard Told, Veronika Vecsei-Marlovits, Stefan Egger, Ulrich Schonherr, Anton Haas, Siamak Ansari-Shahrezaei, Susanne Binder, for the MANTA Research Group2013-03-01BMJ Publishing Group Ltd3972712013-03-01Original articles - Clinical science266